Holen Sie sich die Stockscreener-App
0.8984
14.44%
-0.1516
Vorhandelsmarkt:
.93
0.0316
+3.52%
Sol Gel Technologies Ltd Aktie (SLGL) Neueste Nachrichten
Rosacea Pipeline Analysis, Clinical Trials, EMA, PDMA, FDA - openPR
Actinic Keratosis Treatment Market 2034: EMA, PDMA, FDA Approvals, Prevalence, Clinical Trials, Medication, Therapies, and Companies by DelveInsight - The Globe and Mail
Acne Vulgaris Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, MOA, ROA by DelveInsight | Dermata Therapeutics, AstraZeneca, Novartis, UCB Pharma, Incyte Inc., Galderma - The Globe and Mail
DFD-29: The Journey to FDA Approval and a New Era in Rosacea Management - Dermatology Times
Acne Vulgaris Market Expected to Experience Major Growth by 2034, According to DelveInsight - EIN News
Pre-market Movers: SANA, SLDB, JSPR, DRIO... - RTTNews
Pre-market Movers: CDT, NARI, GDTC, NARI... - RTTNews
Is SolGel Technologies (SLGL) a Great Value Stock Right Now? - Yahoo Finance
There's Reason For Concern Over Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Massive 209% Price Jump - Simply Wall St
Why Carbon Revolution Shares Are Trading Higher By Around 62%; Here Are 20 Stocks Moving Premarket - Benzinga
United States shares higher at close of trade; Dow Jones Industrial Average up 0.16% - Investing.com India
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.16% - Investing.com
SLGL Stock Touches 52-Week High at $1.65 Amid Market Fluctuations - Investing.com
The Next-Generation Solar Cell Market Set to Reach $12.91 Billion by 2031. - openPR
Rosacea Treatment Market Growth in Future Scope 2024-2031 | - openPR
Solar Lighting System Market Trends and Future Opportunities 2024-2032 - openPR
Acne Vulgaris Pipeline Therapeutics Assessment Report 2024 (Updated) - openPR
Global Solar Street Lighting Market to Reach USD 12.38 Billion by 2029, Growing at a CAGR of 14.5% - openPR
Revolutionary Solar Lighting Innovations for 2024 - openPR
Sol-Gel Technologies Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Sol-Gel receives Nasdaq compliance extension By Investing.com - Investing.com Nigeria
Sol-Gel Technologies Reports Strong Q3 2024 Results - TipRanks
SolGel Technologies (SLGL) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Sol-Gel receives Nasdaq compliance extension - Investing.com India
SEALSQ updates on minimum bid price non-compliance - MSN
Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement - The Manila Times
Microlise Group Reassures Investors After Cyber Incident - MSN
Solar Lighting System Market Current Status and Future Prospects till 2031 - openPR
Smudge-Free Innovations: 2024 Global Market Insights on Anti-Fingerprint Coatings In The Latest Report - WhaTech
GlobalData Executes Share Buyback Program - MSN
Sol Gel Tech earnings beat by $0.04, revenue topped estimates - Investing.com South Africa
Sol-Gel Technologies Ltd. (SLGL) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Form 424B3 Sol-Gel Technologies - StreetInsider.com
SEC Form 424B3 filed by Sol-Gel Technologies Ltd. - Quantisnow
Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - The Manila Times
Sol-Gel Technologies Q3 Revenue Surges to $5.4M, Narrows Losses Amid Strategic Growth | SLGL Stock News - StockTitan
Poseida Therapeutics Hosts Cell Therapy R&D Day Highlighting Its Innovative Clinical and Preclinical Pipeline - Yahoo Finance
Tretinoin Market 2024 Trends Evaluation, Geographical - openPR
Solar Lighting Market: Technological Innovations and Future - openPR
Paragon 28, Inc. (FNA) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
SOL (HK) Company Limited Announces Launch of Health-Focused Gevity and Plenty Products - openPR
Rosacea Clinical Trials 2024: EMA, PDMA, FDA Approvals, - openPR
Next-Generation Solar Cell Market Size, Latest Trends, Growth Status, Top Major Players And Forecast To 2033 - openPR
SLGL (Sol-Gel Technologies) 50-Day SMA : $0.66 (As of Nov. 02, 2024) - GuruFocus.com
Rosacea Market Growth, Insights, Demand, Forecast to 2033 - WhaTech
Raymond James Downgrades Sol-Gel Technologies (SLGL) - MSN
(PDF) Effect of various amount of ammonium hydroxide on morphology of silica nanoparticles grown by sol-gel - ResearchGate
Rosacea Treatment Market Size, Share, and Trends Analysis - openPR
Actinic Keratosis Treatment Market Size, Share, Revenue, Trends, and Drivers For 2024-2033 - EIN News
Corrosion and Scale Inhibitors Market to Grow by USD 3.53 Billion (2024-2028) as Demand Surges, with AI Driving Market Transformation- Technavio - Lelezard
Solar Street Lighting Market Trends: USD 38.15 Bn Value with - openPR
Sol-gel Technology Market Leading Players Overview - Economica
Acne Vulgaris Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2024-2034), States DelveInsight | Clinuvel Pharma, Novan, Dermata Therapeutics, ioPharmX, Bausch Health - Barchart
Papulopustular Rosacea Market Revenue to Expand Significantly - openPR
Tretinoin Market Anticipates Positive Growth Through 2031 | BASF, LGM Pharma, Gyma Laboratories. - openPR
Retinoic Acid Receptor Alpha Industry Size, Regional Demand, Trends and Forecast to (2024-2034) - உங்கள் குரல்
4.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):